| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.02 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |